CD8A and neoplasm: Furthermore, the Basal-CD8+Thigh MIBC subgroup showed an enrichment epithelial-to-mesenchymal transition (EMT) signature, suggesting that Basal-CD8+Thigh tumor cells are more invasive and associated with worse clinical outcomes [32].